|
Correlation of serum Semaphorin3A, FGF-23 levels with periodontal indices and disease severity in patients with chronic periodontitis
Xiao Zunsheng, Ding Wencui, Wang Lihui, Jia Huiwen, Jin Yanyan, Li Xinsheng
2025, 34 (4):
403-408.
doi: 10.19439/j.sjos.2025.04.011
PURPOSE: To analyze the correlation of serum Semaphorin3A(Sema3A), fibroblast growth factor 23(FGF-23) levels with periodontal indices and disease severity in patients with chronic periodontitis. METHODS: A total of 115 CP patients admitted to Cangzhou Central Hospital from June 2022 to June 2023 were selected and divided into severe group (34 cases), moderate group (39 cases) and mild group (42 cases) according to the severity of the disease; meanwhile, another 115 healthy individuals with periodontitis who underwent physical examination were selected as the control group. Serum Sema3A and FGF-23 levels of all subjects were detected by enzyme-linked immunosorbent assay (ELISA), and serum inflammatory markers [tumor necrosis factor-α(TNF-α) and interleukin 6 (IL-6), IL-17] and the levels of periodontal indices [gingival index(GI), bleeding index (BI), plaque index (PLI), loss of attachment (AL) and probing depth (PD)] in CP group were detected. Pearson correlation analysis was employed to explore the correlations between the levels of Sema3A and FGF-23 and periodontal parameters and inflammatory markers. Multivariate logistic regression was used to analyze the factors affecting the severity of CP patients. ROC curve was used to evaluate the severity of CP patients with SPSS 25.0 software package. RESULTS: The serum Sema3A level in the CP group was significantly lower than that in the control group, while the FGF-23 level was significantly higher than that in the control group (P<0.05). The serum Sema3A level in mild, moderate, and severe CP group decreased sequentially, while FGF-23 level increased sequentially(P<0.05). The levels of GI, AL, BI, PLI, PD, TNF-α, IL-17 and IL-6 in the mild, moderate, and severe CP groups increased sequentially (P<0.05). The serum Sema3A level was negatively correlated with GI, AL, BI, PLI, PD, TNF-α, IL-17, and IL-6, while the FGF-23 level was positively correlated with the above indicators (P<0.05). Sema3A was a protective factor for exacerbation in CP patients, while FGF-23, GI, AL, BI, PLI, PD, TNF-α, IL-17, and IL-6 were risk factors (P<0.05). The AUC of combined evaluation of serum Sema3A and FGF-23 of the severity of CP patients was 0.919 (95%CI: 0.854-0.962), which was obviously better than a single indicator (P<0.05). CONCLUSIONS: Serum Sema3A is decreased and FGF-23 is increased in CP patients, which is closely related to periodontal parameters and disease severity, and combination evaluation has a high value in estimating the severity of CP patients.
References |
Related Articles |
Metrics
|